This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

Early Savings Deadline Expires In:

  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event
May 9-12, 2022Hynes Convention Center, Boston

Olivier Ludemann-Hombourger, PhD
Global Director Innovation and Strategy at PolyPeptide Group


Olivier Ludemann-Hombourger is the Global Director Innovation & Technology at PolyPeptide. He received his PhD in 2001 from the “Institut National PolyTechnique de Lorraine” in France, in collaboration with Novasep Process, for which he was leading the R&D activity over 10 years. He worked during three years for Lonza in Braine l’Alleud (Belgium) as head of Operations, before joining PolyPeptide as General Manager of the French entity for 7 years, until taking his current global position in 2019.